Literature DB >> 12832457

Multiple sclerosis: an important role for post-translational modifications of myelin basic protein in pathogenesis.

J K Kim1, F G Mastronardi, D D Wood, D M Lubman, R Zand, M A Moscarello.   

Abstract

Myelin basic protein (MBP) represents a candidate autoantigen in multiple sclerosis (MS). We isolated MBP from normal and MS human white matter and purified six components (charge isomers) to compare the post-translational modifications on each. The sites and extent of methylation, deimination, and phosphorylation were documented for all tryptic peptides by mass spectrometry. We found that mono and dimethylated arginine 107 was increased in MS samples; deimination of arginine occurred at a number of sites and was elevated in MS; phosphorylation was observed in 10 peptides in normal samples but was greatly reduced or absent in most peptides from MS samples. Data obtained with MBP isolated from fresh brain obtained from a spontaneously demyelinating mouse model supported the view that the changes observed in human brain were probably related to pathogenesis of demyelination, i.e. we found decreased phosphorylation and decreased amounts of glycogen synthesis kinase in brain homogenates using specific antibodies. This study represents the first to define post-translational modifications in demyelinating disease and suggest an important role in pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12832457     DOI: 10.1074/mcp.M200050-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  60 in total

1.  Organellar proteomics reveals Golgi arginine dimethylation.

Authors:  Christine C Wu; Michael J MacCoss; Gonzalo Mardones; Claire Finnigan; Soren Mogelsvang; John R Yates; Kathryn E Howell
Journal:  Mol Biol Cell       Date:  2004-03-26       Impact factor: 4.138

Review 2.  White matter rafting--membrane microdomains in myelin.

Authors:  Lillian S Debruin; George Harauz
Journal:  Neurochem Res       Date:  2006-09-21       Impact factor: 3.996

3.  Phosphopeptide elution times in reversed-phase liquid chromatography.

Authors:  Jeongkwon Kim; Konstantinos Petritis; Yufeng Shen; David G Camp; Ronald J Moore; Richard D Smith
Journal:  J Chromatogr A       Date:  2007-09-18       Impact factor: 4.759

Review 4.  Myelin architecture: zippering membranes tightly together.

Authors:  Mostafa Bakhti; Shweta Aggarwal; Mikael Simons
Journal:  Cell Mol Life Sci       Date:  2013-10-29       Impact factor: 9.261

5.  Copper uptake induces self-assembly of 18.5 kDa myelin basic protein (MBP).

Authors:  Timo Bund; Joan M Boggs; George Harauz; Nadja Hellmann; Dariush Hinderberger
Journal:  Biophys J       Date:  2010-11-03       Impact factor: 4.033

6.  Post-translational modifications in the rat lumbar spinal cord in experimental autoimmune encephalomyelitis.

Authors:  Jennifer E Grant; Jun Hu; Tong Liu; Mohit R Jain; Stella Elkabes; Hong Li
Journal:  J Proteome Res       Date:  2007-06-13       Impact factor: 4.466

7.  Differences in susceptibility of MBP charge isomers to digestion by stromelysin-1 (MMP-3) and release of an immunodominant epitope.

Authors:  Cheryl A D'Souza; Mario A Moscarello
Journal:  Neurochem Res       Date:  2006-07-27       Impact factor: 3.996

8.  Structured functional domains of myelin basic protein: cross talk between actin polymerization and Ca(2+)-dependent calmodulin interaction.

Authors:  Vladimir V Bamm; Miguel De Avila; Graham S T Smith; Mumdooh A M Ahmed; George Harauz
Journal:  Biophys J       Date:  2011-09-07       Impact factor: 4.033

9.  Backbone resonance assignments of the 18.5 kDa isoform of murine myelin basic protein (MBP).

Authors:  David S Libich; Valerie J Robertson; Martine M Monette; George Harauz
Journal:  J Biomol NMR       Date:  2004-08       Impact factor: 2.835

10.  Deimination of membrane-bound myelin basic protein in multiple sclerosis exposes an immunodominant epitope.

Authors:  Abdiwahab A Musse; Joan M Boggs; George Harauz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.